J&J Consulting Group- FDA Regulatory Compliance
- 1101 California Ave Suite 100 Corona CA 92881
- Info@jjccgroup.org
- (800) 999-7781
FDA PMTA Regulatory Consulting for Tobacco and ENDS Products
Expert FDA PMTA consulting for tobacco, vape, and ENDS products — covering scientific evidence, toxicology, behavioral studies, manufacturing data, and full submission management to ensure FDA authorization and market access.
Call for Appoinment
+ 1 (800) 999-7781
PMTA Introduction
What a PMTA must prove
A Premarket Tobacco Product Application (PMTA) asks FDA for a marketing granted order under section 910 of the FD&C Act. You must show the product is “appropriate for the protection of the public health” (APPH). FDA weighs risks and benefits to the whole population, users and non-users alike, including youth. The content and format rules are in 21 CFR Part 1114.
FDA has issued marketing denial orders for most ENDS applications it has reviewed. In April 2025 the Supreme Court upheld FDA’s approach in FDA v. Wages and White Lion. A well-built application is the only path to market.
Overview of PMTAs
The applicant is usually the manufacturer or brand owner. Retailers, distributors and importers cannot legally sell a new product without a marketing order.
E-cigarettes and vapes, e-liquids, nicotine pouches, heated tobacco, cigars, pipe and hookah tobacco, and components and parts, unless an SE report or SE exemption applies.
Product description and formulation
Ingredients, components, design parameters, specifications
Manufacturing
Process, controls, quality system, stability
Chemistry and HPHCs
Constituent testing, including under intense use
Nonclinical toxicology
Nonclinical toxicology
Under the FDA's "deeming rule," any product that meets the definition of a tobacco product under the FD&C Act must obtain FDA marketing authorization. The following products require a PMTA submission:
Electronic Nicotine Delivery Systems (ENDS): e-cigarettes, vape pens, vape pods, e-liquids, disposable vapes, and refill solutions
Nicotine Pouches: tobacco-free oral nicotine pouches and lozenges
Cigars and Cigarillos: premium, large, and small cigars
Hookah and Waterpipe Tobacco: including shisha and accessories
Pipe Tobacco
Smokeless Tobacco: snus, chewing tobacco, dissolvables
Heated Tobacco Products (HTPs)
Roll-Your-Own (RYO) Tobacco
Any new or modified tobacco product introduced or changed after February 15, 2007
This includes any change in design, components, ingredients, nicotine content, flavor, or delivery system — even minor modifications can require a new or supplemental PMTA.
- 30+ years combined regulatory expertise
- Successfully submitted hundreds PMTA applications
- FDA approvals for new tobacco products
- Comprehensive consumer perception studies completed
- Expertise in HPHC reporting compliance
Our Achievements
Key milestones andachievements
Process ​
PMTA Review Process ​
The PMTA review process includes pre-submission meetings, acceptance review, filing review, substantive scientific evaluation, and post-market reporting compliance.
A voluntary formal meeting between the applicant and FDA to discuss a planned PMTA submission for a tobacco product.
- Meeting granted letter or
- Meeting denial letter
- Meeting minutes letter (if the meeting is granted and held)
- Acceptance letter or
- Refuse to accept (RTA) letter
- Filing letter or
- Refuse to file (RTF) letter
- Deficiency letter: Additional information is needed to complete a scientific review. The letter will specify the number of days an applicant has to respond.
- Environmental information request letter: FDA made a scientific decision to issue a marketing granted order; however, the applicant is required to provide information for environmental considerations before a marketing granted order can be issued.
Clinical study requires meticulous planning and careful execution. Failure to adhere to well-thought study protocol/regiment, may lead to a waste of resources
- Marketing granted order letter or
- Marketing denial order letter
Submit PMTA
How to Submit a PMTA
Acceptance review
FDA checks the application is complete enough to accept, or issues a refuse-to-accept letter.
Filing review
FDA checks it has the content needed for review, or issues a refuse-to-file letter.
Substantive scientific review
reviewers assess the science, may send deficiency letters and may inspect sites.
Action
a marketing granted order (MGO) or marketing denial order (MDO). An MGO carries postmarket reporting duties.
Get Expert Help
Ready to Navigate the PMTA Process Confidently?
plan 12 to 24 months to prepare a complete PMTA, depending on existing data. Budget depends mainly on which studies you need.
How to Prepare
The FDA PMTA Review Process: What You Need to Know
Once submitted, your PMTA undergoes a structured, multi-phase review by the FDA’s Center for Tobacco Products (CTP). Understanding each phase helps you plan, prepare, and respond effectively.
Phase 1: Acceptance Review
An initial administrative review confirming that the product falls under CTP jurisdiction and that the submission meets the statutory and regulatory requirements outlined in 21 CFR § 1114.27(a)(1). Outcome: Acceptance letter or Refuse to Accept (RTA) letter.
A threshold determination assessing whether the application contains sufficient information to permit a full scientific evaluation. Outcome: Filing letter or Refuse to File (RTF) letter under § 1114.27(b)(1).
Phase 3: Substantive Scientific Review
The core of the PMTA evaluation. FDA scientists conduct a deep review of your toxicology, chemistry, behavioral, and manufacturing data — assessing whether your product is "appropriate for the protection of public health." The FDA may issue Deficiency Letters requesting additional information, and applications may be referred to the Tobacco Product Scientific Advisory Committee (TPSAC). Outcome: Continued review, deficiency response, or final action.
Phase 4: Final Decision & Post-Market Compliance
The FDA issues either a Marketing Granted Order (MGO) authorizing market entry, or a Marketing Denial Order (MDO) prohibiting sales. Authorized products are subject to ongoing post-market reporting, adverse experience reporting, and supplemental PMTAs for any product changes.
What to Expect: Timeline & Investment
The PMTA process is a multi-year regulatory commitment. Most manufacturers should plan for:
1–2 years to gather scientific data and prepare submission documents
6–12+ months for FDA acceptance, filing, and substantive review
Ongoing post-market reporting and supplemental filings after authorization
Without proper preparation, applications frequently receive RTA, RTF, or deficiency letters — costing valuable time and resources. JJCC Group helps you avoid these pitfalls with proven submission strategies and FDA-aligned documentation.
Why Choose JJCC Group for PMTA Submission Services
Proven regulatory expertise across ENDS, nicotine pouches, cigars, and emerging tobacco categories
End-to-end submission management — from strategy to authorization
Scientific and technical depth in toxicology, chemistry, and manufacturing
FDA-aligned documentation that minimizes deficiencies and review delays
Ongoing post-market compliance support to keep your products authorized and protected
Whether you're an established tobacco manufacturer, an emerging vape brand, or an importer entering the U.S. market, JJCC Group delivers the regulatory clarity, scientific rigor, and FDA expertise needed to bring your product to market and keep it there.
Best Compliance with 5 Star
99% Happy Clients
Testimonial
Trusted PMTA Regulatory Experts
Their PMTA expertise, documentation accuracy, and FDA communication support helped us avoid delays and regulatory setbacks.
Faqs
Frequently Asked Questions
What is a PMTA, and which products require one?
A PMTA is an application for FDA authorization to market a new tobacco product. ENDS, e-liquids, nicotine pouches, cigars and other new products need one unless an SE pathway applies.
Who submits the PMTA: the manufacturer, the brand or the retailer?
The applicant, usually the manufacturer or brand owner. Retailers cannot sell a new product unless it has a marketing order.
What does "appropriate for the protection of the public health" mean?
It is the APPH standard. FDA weighs the product’s risks and benefits to the whole population, including whether it helps smokers quit and whether it attracts non-users.
What regulation sets PMTA content?
21 CFR Part 1114, which took effect in November 2021. It lists what each application must contain and how FDA reviews it.
What are the phases of FDA's PMTA review?
Acceptance, filing, substantive scientific review, and action: a marketing granted order or a marketing denial order.
Does FDA "approve" tobacco products?
No. FDA issues marketing granted orders. Implying FDA approval or endorsement of a tobacco product is prohibited under the FD&C Act.
How long does the PMTA process take?
Preparation usually takes 12 to 24 months. FDA review often takes a year or more, longer than the 180 days in the statute.
Why are so many PMTAs denied?
Most denials cite missing product-specific evidence, especially for flavored products. FDA wants to see that adult-use benefits outweigh youth risk.
Why are so many PMTAs denied?
The bar is high. You need strong product-specific evidence that the flavor helps adult smokers switch and is not appealing to youth, plus strict marketing controls.
Do I need clinical studies?
FDA does not require one specific study type, but it expects valid scientific evidence. For ENDS that usually includes pharmacokinetic and abuse liability data.
Do I need a consumer perception study?
Not by name, but Part 1114 requires evidence on how consumers perceive the product and its labeling. A perception study is the usual way to provide it.
Can one PMTA cover multiple products?
 Yes. Related products, such as several flavors or nicotine strengths, can be bundled, but each needs its own supporting data.
What happens after a marketing granted order?
You must follow the order’s conditions and submit periodic postmarket reports, including adverse experience data and sales information.
What if we receive a marketing denial order?
You must stop selling. You can request supervisory review, file suit, or submit a new application that fixes the gaps.
Does synthetic nicotine need a PMTA?
Yes. Since April 2022, non-tobacco nicotine products need the same authorization as tobacco-derived products.
What experience does JJCC Group have with PMTAs?
Our founder has spent six years preparing and submitting PMTAs for ENDS companies, working with scientists, engineers, toxicologists and medical advisors.
How much does a PMTA cost?
It depends on what data you already have and which studies are needed. We give you a study plan and budget after a gap assessment.
